title: Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
authors.forename: K
authors.initials: K
authors.lastname: Ruether
authors.forename: T
authors.initials: T
authors.lastname: Pung
authors.forename: U
authors.initials: U
authors.lastname: Kellner
authors.forename: B
authors.initials: B
authors.lastname: Schmitz
authors.forename: C
authors.initials: C
authors.lastname: Hartmann
authors.forename: M
authors.initials: M
authors.lastname: Seeliger
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004596:Electroretinography; D004828:Epilepsies, Partial / Q000188:drug therapy; D006801:Humans; D008297:Male; D012160:Retina / Q000187:drug effects*; D014635:Valproic Acid / Q000627:therapeutic use; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced* / Q000175:diagnosis; D014794:Visual Fields / Q000187:drug effects*; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D020888:Vigabatrin